AmCham EU brings together the expertise of 150+ member companies and follows 80+ policy issues at any point in time.
AmCham EU is a hub of policy expertise. Our blog posts provide insights into the most salient topics for American businesses invested in the EU.
Responsible Business Conduct
The extent of due diligence
Let’s say a consumer wants to know what’s in the granola bar that he or she is about to eat. Easily enough, one can flip the packaging around and read through the information, ranging from the number of calories to the list of ingredients and their micros and macros.
Chips are at the heart of the European Commission’s new strategy to strengthen the semiconductors supply chain and protect Europe’s standing as a world leader in technology.
Transport, Energy & Climate
As the EU debates a Carbon Border Adjustment Mechanism (CBAM), the world will be watching for its impact on international trade, European industry’s competitiveness and global climate objectives.
To some, intellectual property (IP) is an abstract and ambiguous concept, but in fact, it is a crucial driver of the global economy, responsible for 90% of the value of firms in the S&P 500.
Given its outstanding potential, Artificial intelligence (AI) is known as the ‘new electricity’.
Proliferation of labelling requirements for waste disposal across the EU Member states is impeding recycling efforts. The revision of the EU’s Packaging and Packaging Waste Directive provides a chance to design an EU-wide approach to waste sorting and empower consumers by putting them at the centre of recycling efforts.
The COVID-19 pandemic has been an eye-opener for the global trade network. It has exposed the vulnerabilities of the system as well as shedding light on the protectionism that can arise in crisis situations.
In a union built on the principles of the rule of law, recourse to litigation in the event of disputes is an essential ingredient of the justice system. However, access to the justice system is not always equitable: all too often, the (in)ability to bear the costs of legal action is a determinant factor of disputes.
Everyone loves the romance of a tenacious underdog, who charts a course to victory against all the odds. Yet in 2002 when Oakland Athletics transformed from one of Major League Baseball’s perennial whipping boys into a well-oiled winning machine, it was not fortune behind the fairy tale, but cold, calculated data crunching.
Tuberculosis. Gonorrhea. Pneumonia. These bacterial infections, formerly routine to remedy with a course of antibiotics, are becoming increasingly threatening to human health. The reason: antimicrobial resistance (AMR).